Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Immunovant (IMVT) PT Raised to $35 at Chardan Capital Markets
-
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Immunovant (IMVT) Announces Pricing of $121.2 Million Public Offering of Common Stock
-
Immunovant Announces Pricing of $121.2 Million Public Offering
-
Chardan Capital Markets Starts Immunovant (IMVT) at Buy; Named Top 2020 Pick
-
Immunovant Sciences Ltd. Closes Transaction with Health Sciences Acquisitions Corporation

